Adenosine receptor-mediated coronary vascular protection in post-ischemic mouse heart

Life Sciences

Volumn 78, Issue 21, 2006, Pages 2426-2437

  Zatta, Amanda J ^a   Matherne, G Paul ^b   Headrick, John P ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Adenosine receptors; Coronary circulation; Endothelial dysfunction; Ischemia reperfusion

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; [4 [4 (2 FUROYL) 1 PIPERAZINYL] 3 (METHYLSULFONYL)BENZOYL]GUANIDINE; ACETYLCHOLINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; ADENOSINE DIPHOSPHATE; ADENOSINE RECEPTOR; CYCLOHEXYLADENOSINE; ENDOTHELIN RECEPTOR ANTAGONIST; N (4 CYANOPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)PHENOXY]ACETAMIDE; N (4 CYANOPHENYL) 2 [4 (2,6 DIOXO 1,3 DIPROPYL 2,3,4,5,6,7 HEXAHYDRO 1H PURIN 8 YL)PHENOXY]ACETAMIDE; N ACETYL 3,3 DIPHENYL DEXTRO ALANYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN; NITROPRUSSIDE SODIUM; SUPEROXIDE DISMUTASE; TIOPRONIN; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD CELL; BLOOD VESSEL FUNCTION; BLOOD VESSEL INJURY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DESENSITIZATION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPEREMIA; ISOLATED HEART; MALE; MOUSE; NONHUMAN; REPERFUSION INJURY; SENSITIVITY ANALYSIS; TIME; VASODILATATION;

ADENOSINE; ALGORITHMS; ANIMALS; CALCIUM; CORONARY DISEASE; ENDOTHELINS; INDICATORS AND REAGENTS; MICE; MICE, INBRED C57BL; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; OXIDATIVE STRESS; RECEPTORS, PURINERGIC P1; SODIUM-HYDROGEN ANTIPORTER;

EID: 33645995392     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.09.035     Document Type: Article

References (67)

1. + exchange. British Journal of Pharmacology 131 (2000) 659-662
2. Balcells E., Suarez J., and Rubio R. Functional role of intravascular adenosine receptors. European Journal of Pharmacology 210 (1992) 1-9
3. Baxter G.F. The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on. Basic Research in Cardiology 97 (2002) 268-275
4. Brunner F., and Opie L.H. Role of endothelin-A receptors in ischemic contracture and reperfusion injury. Circulation 97 (1998) 391-398
5. Cartier R., Carrier M., Buluran J., Millette D., and Dagenais F. 2,3-butanedione monoxime preserved coronary artery endothelium-dependent relaxation during myocardial ischemia in the isolated rat heart. Canadian Journal of Cardiology 11 (1995) 505-510
6. Dagenais F., Cartier R., Hollmann C., and Buluran J. Calcium-channel blockers preserve coronary endothelial reactivity after ischemia-reperfusion. Annals of Thoracic Surgery 63 (1997) 1050-1056
7. Ding Y., and Vaziri N.D. Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells. Hypertension 32 (1998) 718-723
8. 2-adenosine receptor agonists. Journal of Physiology (London) 541 (2002) 529-543
9. ATP channel blockade. Journal of Clinical Investigation 95 (1995) 285-295
10. Duza T., and Sarelius I.H. Conducted dilations initiated by purines in arterioles are endothelium dependent and require endothelial Ca2+. American Journal of Physiology. Heart and Circulatory Physiology 285 (2003) H26-H37
11. Feuerstein G.Z., and Young P.R. Apoptosis in cardiac diseases: stress- and mitogen-activated signaling pathways. Cardiovascular Research 45 (2000) 560-569
12. Flood A., and Headrick J.P. Functional Characterization of coronary vascular adenosine receptors in the mouse. British Journal of Pharmacology 133 (2001) 1063-1072
13. Flood A.J., Willems L., and Headrick J.P. Coronary function and adenosine receptor mediated responses in ischemic-reperfused mouse heart. Cardiovascular Research 55 (2002) 161-170
14. 3 and bradykinin B2 receptor activation. Circulation Research 81 (1997) 415-422
15. Godecke A., Decking U.K., Ding Z., Hirchenhain J., Bidmon H.J., Godecke S., and Schrader J. Coronary hemodynamics in endothelial NO synthase knockout mice. Circulation Research 82 (1998) 186-194
16. Granger D.N. Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation 6 (1999) 167-178
17. Gryglewski R.J., Chlopicki S., and Niezabitowski P. Endothelial control of coronary flow in perfused guinea pig heart. Basic Research in Cardiology 90 (1995) 119-124
18. 3 adenosine receptor activation and gene knock-out in ischemic-reperfused mouse heart. Cardiovascular Research 53 (2002) 147-155
19. Hassanabad Z.F., Furman B.L., Parratt J.R., and Aughey E. Coronary endothelial dysfunction increases the severity of ischaemia-induced ventricular arrhythmias in rat isolated perfused hearts. Basic Research in Cardiology 93 (1998) 241-249
20. Headrick J.P., Hack B., and Ashton K.J. Acute adenosinergic cardioprotection in ischemic-reperfused hearts. American Journal of Physiology. Heart and Circulatory Physiology 285 (2003) H1797-H1818
21. Indik J.H., Goldman S., and Gaballa M.A. Oxidative stress contributes to vascular endothelial dysfunction in heart failure. American Journal of Physiology. Heart and Circulatory Physiology 281 (2001) H1767-H1770
22. + channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise. Circulation Research 82 (1998) 346-359
23. 3 receptors: novel ligands and paradoxical effects. Trends in Pharmacological Sciences 19 (1998) 184-191
24. 2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. Journal of Pharmacology and Experimental Therapeutics 280 (1997) 301-309
25. Jordan J.E., Zhao Z.Q., and Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovascular Research 43 (1999) 860-878
26. 2B adenosine receptors. Journal of Medicinal Chemistry 43 (2000) 1165-1172
27. 1 adenosine receptor. Basic Research in Cardiology 96 (2001) 487-496
28. Kolocassides K.G., Galinanes M., and Hearse D.J. Ischemic preconditioning, cardioplegia or both? Differing approaches to myocardial and vascular protection. Journal of Molecular and Cellular Cardiology 28 (1996) 623-634
29. Kostic M.M., and Schrader J. Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circulation Research 70 (1992) 208-212
30. + exchanger. Circulation Research 68 (1991) 269-279
31. Kurzelewski M., Czarnowska E., and Beresewicz A. Endothelin in the mechanism of endothelial injury and neutrophil adhesion in the post-ischemic guinea-pig heart. European Journal of Pharmacology 434 (2002) 95-107
32. 2a agonist CGS-21680 in infarcted and stunned porcine myocardium. American Journal of Physiology. Heart and Circulatory Physiology 280 (2001) H1660-H1666
33. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annual Review of Pharmacology and Toxicology 41 (2001) 775-787
34. Li X., Wang Q.D., and Pernow J. Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat. European Journal of Pharmacology 283 (1995) 161-168
35. Ma X.L., Lopez B.L., Liu G.L., Christopher T.A., and Ischiropoulos H. Peroxynitrite aggravates myocardial reperfusion injury in the isolated perfused rat heart. Cardiovascular Research 36 (1997) 195-204
36. Maczewski M., and Beresewicz A. The role of endothelin, protein kinase C and free radicals in the mechanism of the post-ischemic endothelial dysfunction in guinea-pig hearts. Journal of Molecular and Cellular Cardiology 32 (2000) 297-310
37. 2+ exchange in rat heart. European Journal of Pharmacology 461 (2003) 139-147
38. Maggirwar S.B., Dhanraj D.N., Somani S.M., and Ramkumar V. Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochemical and Biophysical Research Communications 201 (1994) 508-515
39. 1 adenosine receptor over-expression increases myocardial resistance to ischemia. Proceedings of the National Academy of Sciences of the United States of America 94 (1997) 6541-6546
40. Merkus D., Stepp D.W., Jones D.W., Nishikawa Y., and Chilian W.M. Adenosine preconditions against endothelin-induced constriction of coronary arterioles. American Journal of Physiology 279 (2000) H2593-H2597
41. Mehta J.L., Nichols W.W., Donnelly W.H., Lawson D.L., Thompson L., ter Riet M., and Saldeen T.G.P. Protection by superoxide dismutase from myocardial dysfunction and attenuation of vasodilator reserve after coronary occlusion and reperfusion in dog. Circulation Research 65 (1989) 1283-1295
42. 2+ channel activity via protein tyrosine phosphatase, not cAMP-dependent protein kinase. Molecular Pharmacology 64 (2003) 640-649
43. 1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes. Journal of Molecular and Cellular Cardiology 33 (2001) 121-129
44. Nieminen A.L. Apoptosis and necrosis in health and disease: role of mitochondria. International Review of Cytology 224 (2003) 29-55
45. Pannangpetch P., and Woodman O.L. The effect of ischaemia on endothelium-dependent vasodilatation and adrenoceptor-mediated vasoconstriction in rat isolated hearts. British Journal of Pharmacology 117 (1996) 1047-1052
46. Perreault C.L., Mulieri L.A., Alpert N.R., Ransil B.J., Allen P.D., and Morgan J.P. Cellular basis of negative inotropic effect of 2,3-butanedione monoxime in human myocardium. American Journal of Physiology. Heart and Circulatory Physiology 263 (1992) H503-H510
47. Piper H.M., Meuter K., and Schafer C. Cellular mechanisms of ischemia-reperfusion injury. Annals of Thoracic Surgery 75 (2003) S644-S648
48. 6-(2-phenylisopropyl)-adenosine following regional ischemia and reperfusion in canine myocardium. Biochimica et Biophysica Acta 1361 (1997) 295-303
49. Reffelmann T., and Kloner R.A. Is microvascular protection by cariporide and ischemic preconditioning causally linked to myocardial salvage?. American Journal of Physiology. Heart and Circulatory Physiology 284 (2003) H1134-H1141
50. Scarabelli T., Stephanou A., Rayment N., Pasini E., Comini L., Curello S., Ferrari R., Knight R., and Latchman D. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 104 (2001) 253-256
51. Schachinger V., Britten M.B., and Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction adverse long-term outcome of coronary heart disease. Circulation 101 (2000) 1899-1906
52. Solenkova N.V., Solodushko V., Cohen M.V., and Downey J.M. Endogenous adenosine protects the preconditioned heart during the early minutes of reperfusion by activating Akt. American Journal of Physiology. Heart and Circulatory Physiology (2005 (Sep 9)) (Epub ahead of print)
53. 3 receptors augments adenosine-induced coronary flow in isolated mouse hearts. American Journal of Physiology. Heart and Circulatory Physiology 282 (2002) H2183-H2189
54. Tomasian D., Keaney J.F., and Vita J.A. Antioxidants and the bioactivity of endotheliumderived nitric oxide. Cardiovascular Research 47 (2000) 426-435
55. 3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart. Cardiovascular Research 33 (1997) 410-415
56. Tsao P.S., and Lefer A.L. Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts. American Journal of Physiology. Heart and Circulatory Physiology 259 (1990) H1660-H1666
57. Otun H., Gillespie J.I., Greenwell J.R., and Dunlop W. The actions of caffeine and 2,3-butandione monoxime on calcium transients in human vascular smooth muscle. Experimental Physiology 78 (1993) 255-258
58. Vanden Hoek T., Becker L.B., Shao Z.H., Li C.Q., and Schumacker P.T. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circulation Research 86 (2000) 541-548
59. Vinten-Johansen J., Thourani V.H., Ronson R.S., Jordan J.E., Zhao Z.Q., Nakamura M., Velez D., and Guyton R.A. Broad-spectrum cardioprotection with adenosine. Annals of Thoracic Surgery 68 (1999) 1942-1948
60. Volkov A.M., Kazanskaya G.M., Chasovskikh G.G., D'yakonitsa T.M., Zhdanov G.P., and Lomivorotov V.N. Effect of calcium antagonists on ultrastructure of myocardial microvessels during open heart surgery under conditions of pharmacological and cold cardioplegia. Bulletin of Experimental Biology and Medicine 132 (2001) 827-831
61. Wang P., and Zweier J.L. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury. Journal of Biological Chemistry 271 (1996) 29223-29230
62. Watanabe M. Effect of 2,3-butanedione monoxime on smooth-muscle contraction of guinea-pig portal vein. Pflugers Archiv 425 (1993) 462-468
63. Waurick R., Knapp J., Van Aken H., Boknik P., Neumann J., and Schmitz W. Effect of 2,3-butanedione monoxime on force of contraction and protein phosphorylation in bovine smooth muscle. Naunyn-Schmiedeberg's Archives of Pharmacology 359 (1999) 484-492
64. Weiss J.N., Korge P., Honda H.M., and Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circulation Research 93 (2003) 292-301
65. Woodman O.L. Approaches to the prevention of coronary vascular dysfunction caused by myocardial ischaemia and reperfusion. Current Pharmaceutical Design 5 (1999) 1077-1087
66. + exchange inhibitor, SM-20550, on ischemia/reperfusion-induced endothelial dysfunction in isolated perfused rat hearts. International Journal on Tissue Reactions 23 (2001) 1-7
67. 2+ release in rat heart. Cardiovascular Research 50 (2001) 56-64